An attenuation mechanism of Newcastle disease vaccine strain TCND

Archives of Virology

Volumn 143, Issue 6, 1998, Pages 1129-1143

  Takakuwa, H ^a   Ito, T ^b   Takada, A ^a   Okazaki, K ^a   Kida, H ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID ANALYSIS; ASSAY; BIRD DISEASE; CELL CULTURE; GENETIC TRANSCRIPTION; HEMADSORPTION; HEMAGGLUTININ NEURAMINIDASE; HYBRID PROTEIN; IMMUNOFLUORESCENCE; INCUBATION; MUTANT; PROTEIN SYNTHESIS; RESIDUE; VACCINE; VIRAL GENETICS; VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; HN PROTEIN; MOLECULAR SEQUENCE DATA; NEWCASTLE DISEASE VIRUS; RNA, VIRAL; TEMPERATURE; VACCINES, ATTENUATED; VIRAL FUSION PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0031903579     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050361     Document Type: Article

References (35)

1. Abenes G, Kida H, Yanagawa R (1986) Antigenic mapping and funcitonal analysis of the F protein of Newcastle disease virus using monoclonal antibodies. Arch Virol 90: 97-110
2. Abenes GB, Kida H, Yanagawa R (1986) Biological activities of monoclonal antibodies to the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus. Jpn J Vet Sci 48: 353-362
3. Allan WH, Lancaster JE, Toth B (1978) Newcastle disease vaccines. Food and Agriculture Organisation of the United Nations, Rome, pp 74-79
4. Bankowski RA (1958) A tissue culture-modified Newcastle disease virus. I. Modification, propagation and characteristics of the tissue culture Newcastle disease virus. Avian Dis 2: 197-207
5. Bean WJ, Sriram G, Webster RG (1980) Electrophoretic analysis of iodine-labeled influenza virus RNA segments. Anal Biochem 102: 228-232
6. Bratt MA (1969) RNA synthesis in chick embryo cells infected with different strains of NDV. Virology 38: 485-488
7. Bratt MA, Gallaher WR (1969) Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci USA 64: 536-543
8. Gallaher WR, Levitan DB, Blough HA (1973) Effect of 2-deoxy-D-glucose on cell fusion induced by Newcastle disease and herpes simplex viruses. Virology 55: 193-201
9. Garten W, Berk W, Nagai Y, Rott R, Klenk HD (1980) Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity. J Gen Virol 50: 135-147
10. Gelb J Jr, King DJ, Wisner WA, Ruggeri PA (1996) Attenuation of lentogenic Newcastle disease virus strain B-1 by cold adaptation. Avian Dis 40: 605-612
11. Gits J, Zygraich N (1978) Potential as an aerosol vaccine of an improved Newcastle disease vaccine derived from the Lasota strain-1. In vitro studies. Comp Immunol Microbiol Infect Dis 1: 49-58
12. Kato A, Kiyotani K, Sakai Y, Yoshida T, Nagai Y (1997) The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 16: 578-587
13. Kato A, Kiyotani K, Sakai Y, Yoshida T, Shioda T, Nagai Y (1997) Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol 71: 7 266-7 272
14. Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, Nagai Y (1996) initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1: 569-579
15. Kawasaki ES (1990) Amplification of RNA. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols: a guide to methods and amplifications. Academic Press, New York, pp 21-27
16. Kida H, Yanagawa R (1981) Classification of avian paramyxoviruses by immunodiffusion on the basis of antigenic specificity of their M protein antigens. J Gen Virol 52: 103-111
17. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
18. Lwoff A (1959) Factors influencing the evolution of virual diseases at the cellular level and in the organism. Bacteriol Rev 23: 109-124
19. Maassab HF (1967) Adaptation and growth characterisitcs of influenza virus at 25 degrees C. Nature 213: 612-614
20. Matsumura H, Futaesaku Y, Kohno S, Sugiura A, Kohase M (1990) A temperature-sensitive mutant of Newcastle disease virus defective in intracellular processing of fusion protein. J Virol 64: 1 410-1 413
21. Morrison T, McQuain C, McGinnes L (1991) Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol 65: 813-822
22. Nagai Y, Hamaguchi M, Toyoda T (1989) Molecular biology of Newcastle disease virus. Prog Vet Microbiol Immunol 5: 16-64
23. Nagai Y, Klenk HD (1977) Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage. Virology 77: 125-134
24. Nagai Y, Klenk HD, Rott R (1976) Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494-508
25. Nagai Y, Shimokata K, Yoshida Y, Hamaguchi M, Iinuma M, Maeno K, Matsumoto T, Klenk HD, Rott R (1979) The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins. J Gen Virol 45: 263-272
26. Peeples ME (1988) Differential detergent treatment allows immunofluorescent localization of the Newcastle disease virus matrix protein within the nucleus of infected cells. Virology 162: 255-259
27. Peeples ME, Glickman RL, Gallagher JP, Bratt MA (1988) Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity. Virology 164: 284-289
28. Portner A, Scroggs RA, Marx PS, Kingsbury DW (1975) A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology 67: 179-187
29. Richardson CD, Scheid A, Choppin PW (1980) Specific inhibition of paramyxoviurs and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology 105: 205-222
30. Richman DD, Murphy BR (1979) The association of the temperature-sensitive phenotype with viral attenuation in animals and humans: implication of the development and use of live virus vaccines. Rev Infect Dis 1: 413-433
31. Sever JL (1962) Application of microtechnique to viral serological investigations. J Immunol 88: 320-329
32. Smith GW, Hightower LE (1992) Revenant analysis of a temperature-sensitive mutant of Newcastle disease virus with defective glycoproteins: implication of the fusion glycoprotein in cell killing and isolation of a neuraminidase-deficient hemagglutinating virus. J Virol 42: 659-668
33. Toyoda T, Sakaguchi T, Imai K, Incocencio NM, Gotoh B, Hamaguchi M, Nagai Y (1987) Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158: 242-247
34. Tsipis JE, Bratt MA (1976) Isolation and preliminary characterization of temperature-sensitive mutants of Newcastle disease virus. J Virol 18: 848-855
35. Zygraich N, Renaut F, Gits J (1978) Potential as an aerosol vaccine of an improved Newcastle disease vaccine derived from the La Sota strain-II. In vivo studies. Comp Immunol Microbiol Infect Dis 1: 59-66